Studies have demonstrated that in animals exposed to ischemia–reperfusion injury (I/R), higenamine can reduce the size of myocardial infarction and apoptosis; this effect can be mitigated by PI3K/Akt pathway inhibitors. Here, AKT1 is linked to myocardial infarction.